<script src="/scripts/jquery.magnific-popup.min.js"></script>

Marco Costa, MD, PhD

Watch to find out more about this University Hospitals physician.

Specializes in:
Cardiology
Cardiology-Interventional Cardiology

President, Harrington Heart and Vascular Institute, UH Institutes
Professor, Medicine, CWRU School of Medicine
Chief Innovation Officer, University Hospitals
Director, Interventional Cardiovascular Center, University Hospitals
President, Harrington Heart and Vascular Institute, University Hospitals

(216)844-3800

Gender: Male

Office Locations

UH Cleveland Medical Center
(216)844-3800
Department of Medicine-Cardiovascular Medicine
11100 Euclid Ave
Cleveland, OH 44106
Get Directions

UH Chagrin Highlands Health Center
(216)844-3800
3909 Orange Pl
Ste 3300
Orange Village, OH 44122
Get Directions

UH Euclid Health Center
(216)844-3800
18599 Lakeshore Blvd
Ste 300
Euclid, OH 44119
Get Directions

Expertise

Structural Heart Disease, Optical Coherence Tomography, Percutaneous Valve Repair, Endovascular Procedures, Interventional Cardiology, Cardiac Catheterization, Cardiovascular Medicine, Stem Cell Therapy, Cardiovascular Imaging

Education & Training

Medical / Professional School(s):
1994, Universidade Federal de Minas Gerais, Faculdade de Medicina

Internship:
1994, Internal Medicine - Universidade Federal de Minas Gerais, Faculdade de Medicina

Residency:
1996, Cardiovascular Disease - Hospital Felicio Rocho

Fellowship:
1998, Interventional Cardiology - Hospital Felicio Rocho
2000, Interventional Cardiology - Erasmus Universiteit Faculteit der Geneeskunde

Research Fellowship:
1994, Cardiothoracic Anesthesia - Cleveland Clinic

Patient Satisfaction Reviews

About Our Survey

At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.

Learn More

Patient Comments

There are no comments for this practitioner.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2015, Marco Costa, MD, PhD disclosed the following Outside Relationships with Industry:


Abbott Laboratories - Consulting

Boston Scientific Corp - Consulting

Cardiokinetix - Consulting

Cordis Corporation - Consulting

Daiichi-Sankyo - Consulting

Eli Lilly Pharmaceuticals Company - Consulting

Medtronic, Inc. - Consulting

Sanofi-Aventis - Consulting

Scitech Medical, Inc. - Consulting

St Jude Medical, Inc. - Consulting

St. Jude Medical, Inc. - Consulting

CardioKenetix - Consulting payments

Abbott Vascular - Honoraria

Edwards Lifesciences - Honoraria

Medtronic, Inc. - Honoraria

Genae Americas - Ownership

Genae Americas - Ownership

StemMed Inc. - Ownership

There is no publicly available rating for this medical professional because he or she either does not see patients or has not yet received the minimum number of Patient Satisfaction Reviews. To be eligible for display, we require a minimum of 30 surveys. This ensures that the rating is statistically reliable and a true reflection of patient satisfaction.

UH Quality Care Network, is a collaboration among independent and UH employed providers. The focus is on improving the quality and efficiency of care, as well as reducing the cost of care.